Surrey Heartlands

Joint Formulary & PAD

Capsaicin - Pain (Neuropathic)

You are here : Home > Formulary Search > Capsaicin - Pain (Neuropathic)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Cream
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NICE
Restrictions / Comments :
Important
0.075% cream (Axsain brand) is licensed for this indication
 

Status 2

Red
Formulations :
  • Patches
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

To be initiated by specialist pain care teams only

Documents :
 
Policy Statement
Capsaicin (Qutenza) Cutaneous Patch- Change in colour classification - Oct 24.pdf

Documentation

Guidelines (National)
NICE Clinical guideline [CG173] : Neuropathic pain in adults: pharmacological management in non-specialist settings

PAD Profile

ChemicalSubstance :
Capsaicin
Indication :
Pain (Neuropathic)
Group Name :
Keywords :
neuropathic pain, diabetic neuropathy, post-herpetic neuralgia, PHN
Brand Names Include :
Axsain, Qutenza
Important Information :
For patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine)
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Capsaicin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pain (Neuropathic).

Committee Recommendations (2)

04 Sep 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) approves the use of capsaicin patches for the treatment of neuropathic pain when prescribed by specialist pain teams within a secondary care setting only.

 

The APC recommend a RED traffic light status for the use of capsaicin patches for this indication only.

 

Primary care prescribers should be aware that their patient is receiving this medicine and ensure that this is recorded on the patient’s medication screen as a hospital-only drug in line with guidance on the PAD. This will also alert the prescriber to potential side effects and interactions with other medicines prescribed in primary care. It will also ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.”

07 Oct 20 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Capsaicin cream 0.075% (Axsain) is recommended for patients with localised neuropathic pain who cannot tolerate / wish to avoid oral treatments (amitriptyline or duloxetine).